|

NVAX Stock Price: Novavax, Inc. keeps the $143.00 mark so far

  • Novavax, Inc. (NASDAQ: NVAX) trades around Thursday’s close near $143.00.
  • Progress on its vaccine candidate remains in centre stage.

Shares of biotech Novavax, Inc. (NASDAQ: NVAX) remain mostly flat near Thursday’s close just above the $143.00 mark during the premarket activity.

Choppy week for (NASDAQ: NVAX) so far, which saw weekly gains advancing to the area past the $155.00 level at the beginning of the week, embarking into a corrective downside soon afterwards.

The US biotech stays in the centre of the debate as investors continue to monitor the progress on its COVID-19 vaccine candidate NVX-CoV2373, sharing the run up to finally develop an efficient vaccine with fellow competitors Moderna, Inc. and Pfizer, Inc.

So far this year, (NASDAQ: NVAX) is already advancing nearly 3,500%.

Novavax Stock Forecast

As of writing, (NASDAQ: NVAX) is losing 0.09% at $143.13 and faces the next support at $112.51 (monthly low Aug.11) and then $93.49 (low Jul.9). On the other hand, the next hurdle lines up at $155.75 (high Aug.17) seconded by $189.40 (high Aug.5).

Author

Pablo Piovano

Born and bred in Argentina, Pablo has been carrying on with his passion for FX markets and trading since his first college years.

More from Pablo Piovano
Share:

Editor's Picks

GBP/USD: Downward-sloping trendline near 1.3470 remains key barrier

The British pound faces selling pressure against its major currency peers, trading 0.1% lower at around 1.3420 against the US Dollar during the European trading session on Tuesday.

Euro defends 1.1500 level ahead of US data

EUR/USD struggles to make a decisive move in either direction and trades in a tight channel above 1.1500 on Tuesday. Investors cling to a cautious stance amid the uncertainty surrounding the situation in the Middle East and help the USD stay resilient against its rivals, limiting the pair's upside ahead of the next batch of US data.

Ripple Price Forecast: XRP extends technical weakness despite whales increasing exposure
Ripple (XRP) declines for a second day in a row, trading around $1.07 at the time of writing on Tuesday. The remittance token has continued to sustain a bearish outlook, aligning with the broader cryptocurrency market.
Volatility waits for fresh catalyst ahead of US-Iran 'talks'
EU mid-market update: SpaceX and AMD to report after the close; Volatility waits for fresh catalyst ahead of US-Iran 'talks'. - Middle East and energy drives sentiment still.
9-3: Is the Federal Reserve’s vote tally Warsh's new forward guidance?
The rate did not move. Neither did the statement, and that’s the more interesting fact. Set the July 29 Federal Open Market Committee (FOMC) statement beside the one issued on June 17, and the two documents are identical apart from a single verb and a paragraph at the bottom naming three dissenters.